/PRNewswire/ Cell & Gene Therapy Clinical Trials Market Research Report by Phase, Application, Region - Global Forecast to 2027 - Cumulative Impact of.
Sequoia, GIC invest in TPG-backed Novotech at $2.3b valuation
Hands of clinician holding steel tools during scientific experiment in laboratory (Photo Source: Internet Archive)
February 1, 2021
Sequoia Capital and Singapore sovereign fund GIC Pte are among investors that agreed to buy a stake in clinical research and testing provider Novotech Pty from TPG, people with knowledge of the matter said.
Kaiser Foundation Hospitals also plans to invest in Novotech, according to the people, who asked not to be identified because the information is private. TPG is selling more than 10% of Novotech in a transaction valuing the company at over $2.3 billion, said Joel Thickins, head of Australia and New Zealand for TPG Capital Asia.